Aardvark Therapeutics, Inc. Common Stock (AARD) has a consensus analyst rating of Buy, based on 8 analysts covering the stock. Of those, 4 recommend buying, 4 recommend holding, and 0 recommend selling.
The analyst consensus price target for AARD is $29.33, representing a +477.4% upside from the current price of $5.08. Price targets range from a low of $6.00 to a high of $47.00.
